Scientific Literature Search

Source record

Toward neuroprotective treatments of Parkinson's disease.

Kim KS.

Proc Natl Acad Sci U S A · 2017-03-30

DOI: 10.1073/pnas.1703362114PMID: 28360200

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.

Andersen AD, Blaabjerg M, Binzer M, Kamal A, Thagesen H, Kjaer TW, Stenager E, Gramsbergen JBP.

J Neurochem · 2017-03-30

DOI: 10.1111/jnc.13997PMID: 28244186

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Modulating mitochondrial pyruvate carrier: A promising therapeutic target in Parkinson's disease.

Orgaz L, Bueno Gil G.

Mov Disord · 2017-03-30

DOI: 10.1002/mds.26962PMID: 28370579

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease.

Fox SH, Metman LV, Nutt JG, Brodsky M, Factor SA, Lang AE, Pope LE, Knowles N, Siffert J.

Mov Disord · 2017-03-30

DOI: 10.1002/mds.26976PMID: 28370447

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.

Nam MH, Park M, Park H, Kim Y, Yoon S, Sawant VS, Choi JW, Park JH, Park KD, Min SJ, Lee CJ, Choo H.

ACS Chem Neurosci · 2017-03-30

DOI: 10.1021/acschemneuro.7b00050PMID: 28332824

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?

Laloux C, Gouel F, Lachaud C, Timmerman K, Do Van B, Jonneaux A, Petrault M, Garcon G, Rouaix N, Moreau C, Bordet R, Duce JA, Devedjian JC, Devos D.

Neurobiol Dis · 2017-03-29

DOI: 10.1016/j.nbd.2017.03.013PMID: 28363801

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.

Spathis AD, Asvos X, Ziavra D, Karampelas T, Topouzis S, Cournia Z, Qing X, Alexakos P, Smits LM, Dalla C, Rideout HJ, Schwamborn JC, Tamvakopoulos C, Fokas D, Vassilatis DK.

Proc Natl Acad Sci U S A · 2017-03-27

DOI: 10.1073/pnas.1616874114PMID: 28348207

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Levodopa-Responsive Parkinsonism Associated with Giant Virchow-Robin Spaces: A Case Report.

Shoeibi A, Litvan I.

Mov Disord Clin Pract · 2017-03-27

DOI: 10.1002/mdc3.12484PMID: 30713969

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Berger NA, Besson VC, Boulares AH, Bürkle A, Chiarugi A, Clark RS, Curtin NJ, Cuzzocrea S, Dawson TM, Dawson VL, Haskó G, Liaudet L, Moroni F, Pacher P, Radermacher P, Salzman AL, Snyder SH, Soriano FG, Strosznajder RP, Sümegi B, Swanson RA, Szabo C.

Br J Pharmacol · 2017-03-26

DOI: 10.1111/bph.13748PMID: 28213892

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Classification of advanced stages of Parkinson's disease: translation into stratified treatments.

Krüger R, Klucken J, Weiss D, Tönges L, Kolber P, Unterecker S, Lorrain M, Baas H, Müller T, Riederer P.

J Neural Transm (Vienna) · 2017-03-24

DOI: 10.1007/s00702-017-1707-xPMID: 28342083

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Levodopa Responsive Parkinsonism in Patients with Hemochromatosis: Case Presentation and Literature Review.

Girotra T, Mahajan A, Sidiropoulos C.

Case Rep Neurol Med · 2017-03-23

DOI: 10.1155/2017/5146723PMID: 28424751

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Levodopa response differs in Parkinson's motor subtypes: A task-based effective connectivity study.

Mohl B, Berman BD, Shelton E, Tanabe J.

J Comp Neurol · 2017-03-23

DOI: 10.1002/cne.24197PMID: 28256710

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

20.703 articles found

Toward neuroprotective treatments of Parkinson's disease.

Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.

Modulating mitochondrial pyruvate carrier: A promising therapeutic target in Parkinson's disease.

Trial of dextromethorphan/quinidine to treat levodopa-induced dyskinesia in Parkinson's disease.

Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease.

Continuous cerebroventricular administration of dopamine: A new treatment for severe dyskinesia in Parkinson's disease?

Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.

Levodopa-Responsive Parkinsonism Associated with Giant Virchow-Robin Spaces: A Case Report.

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Classification of advanced stages of Parkinson's disease: translation into stratified treatments.

Levodopa Responsive Parkinsonism in Patients with Hemochromatosis: Case Presentation and Literature Review.

Levodopa response differs in Parkinson's motor subtypes: A task-based effective connectivity study.

Filters